$AMRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMARIN CORP PLC\UK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMARIN CORP PLC\UK. Get notifications about new insider transactions in AMARIN CORP PLC\UK for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 12 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 21.37 | 600 | 12,821 | 217,934 | 218.5 K to 217.9 K (-0.27 %) |
| Nov 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 20.72 | 22,707 | 470,541 | 218,534 | 241.2 K to 218.5 K (-9.41 %) |
| Nov 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 2.50 | 18,750 | 46,875 | 241,241 | 222.5 K to 241.2 K (+8.43 %) |
| Nov 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.40 | 2,604 | 3,646 | 222,491 | 219.9 K to 222.5 K (+1.18 %) |
| Nov 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.02 | 1,953 | 1,992 | 219,887 | 217.9 K to 219.9 K (+0.90 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 0.00 | 31,153 | 0 | 31,153 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | A | 3.21 | 46,973 | 150,783 | 46,973 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | VAN HEEK G JAN | Director | Option Exercise | A | 0.00 | 31,153 | 0 | 31,153 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | VAN HEEK G JAN | Director | Option Exercise | A | 3.21 | 46,973 | 150,783 | 46,973 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | M | 0.00 | 37,500 | 0 | 112,500 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Payment of Exercise | F | 16.27 | 14,757 | 240,096 | 2,294,528 | 2.3 M to 2.3 M (-0.64 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Buy | M | 0.00 | 37,500 | 0 | 2,309,285 | 2.3 M to 2.3 M (+1.65 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | STACK DAVID M | Director | Option Exercise | A | 0.00 | 31,153 | 0 | 31,153 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | STACK DAVID M | Director | Option Exercise | A | 3.21 | 46,973 | 150,783 | 46,973 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Peterson Kristine | Director | Option Exercise | A | 0.00 | 31,153 | 0 | 31,153 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Peterson Kristine | Director | Option Exercise | A | 3.21 | 46,973 | 150,783 | 46,973 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | O'Sullivan Patrick J | Director | Option Exercise | A | 0.00 | 31,153 | 0 | 31,153 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | O'Sullivan Patrick J | Director | Option Exercise | A | 3.21 | 46,973 | 150,783 | 46,973 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 1.40 | 2,604 | 3,646 | 41,666 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 4,167 | 10,418 | 37,499 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 3,312 | 8,280 | 64,188 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 3,750 | 9,375 | 33,750 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.95 | 2,771 | 8,174 | 78,082 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.77 | 100,000 | 877,000 | 0 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.77 | 200,000 | 1,754,000 | 100,000 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 17.20 | 116,604 | 2,005,589 | 341,297 | 457.9 K to 341.3 K (-25.46 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 1.40 | 2,604 | 3,646 | 457,901 | 455.3 K to 457.9 K (+0.57 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 4,167 | 10,418 | 455,297 | 451.1 K to 455.3 K (+0.92 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 3,312 | 8,280 | 451,130 | 447.8 K to 451.1 K (+0.74 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 3,750 | 9,375 | 447,818 | 444.1 K to 447.8 K (+0.84 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.95 | 2,771 | 8,174 | 444,068 | 441.3 K to 444.1 K (+0.63 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.77 | 100,000 | 877,000 | 441,297 | 341.3 K to 441.3 K (+29.30 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 16.00 | 100,000 | 1,600,000 | 341,297 | 441.3 K to 341.3 K (-22.66 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 15.00 | 100,000 | 1,500,000 | 441,297 | 541.3 K to 441.3 K (-18.47 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.77 | 200,000 | 1,754,000 | 541,297 | 341.3 K to 541.3 K (+58.60 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 1.40 | 2,604 | 3,646 | 41,666 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 2.50 | 18,749 | 46,873 | 168,760 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 1.02 | 1,953 | 1,992 | 7,812 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 47,188 | 0 | 141,562 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 17.99 | 8,400 | 151,129 | 217,934 | 226.3 K to 217.9 K (-3.71 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 17.47 | 8,800 | 153,696 | 226,334 | 235.1 K to 226.3 K (-3.74 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 16.33 | 33,049 | 539,703 | 235,134 | 268.2 K to 235.1 K (-12.32 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.40 | 2,604 | 3,646 | 268,183 | 265.6 K to 268.2 K (+0.98 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 2.50 | 18,749 | 46,873 | 265,579 | 246.8 K to 265.6 K (+7.60 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.02 | 1,953 | 1,992 | 246,830 | 244.9 K to 246.8 K (+0.80 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Payment of Exercise | F | 16.27 | 26,495 | 431,074 | 244,877 | 271.4 K to 244.9 K (-9.76 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 6,250 | 0 | 271,372 | 265.1 K to 271.4 K (+2.36 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 47,188 | 0 | 265,122 | 217.9 K to 265.1 K (+21.65 %) |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 0.00 | 34,269 | 0 | 34,269 | |
| Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 3.21 | 51,671 | 165,864 | 51,671 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 500,000 | 1,700,000 | 1,050,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 12.18 | 65,800 | 801,319 | 226,047 | 291.8 K to 226 K (-22.55 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 11.23 | 26,949 | 302,678 | 291,847 | 318.8 K to 291.8 K (-8.45 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 10.30 | 407,251 | 4,195,337 | 318,796 | 726 K to 318.8 K (-56.09 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 500,000 | 1,700,000 | 726,047 | 226 K to 726 K (+221.19 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.77 | 200,000 | 1,754,000 | 300,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.77 | 100,000 | 877,000 | 500,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.10 | 33,750 | 273,375 | 0 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.95 | 52,147 | 153,834 | 80,853 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 142,500 | 356,250 | 37,500 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 112,500 | 281,250 | 67,500 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 158,334 | 395,835 | 41,666 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 1.40 | 20,834 | 29,168 | 44,270 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 14.00 | 100,000 | 1,400,000 | 341,297 | 441.3 K to 341.3 K (-22.66 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 13.00 | 100,000 | 1,300,000 | 441,297 | 541.3 K to 441.3 K (-18.47 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.77 | 200,000 | 1,754,000 | 541,297 | 341.3 K to 541.3 K (+58.60 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 12.00 | 100,000 | 1,200,000 | 341,297 | 441.3 K to 341.3 K (-22.66 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 10.94 | 49,450 | 540,869 | 441,297 | 490.7 K to 441.3 K (-10.08 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 10.04 | 529,791 | 5,319,155 | 490,747 | 1 M to 490.7 K (-51.91 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.77 | 100,000 | 877,000 | 1,020,538 | 920.5 K to 1 M (+10.86 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.10 | 33,750 | 273,375 | 920,538 | 886.8 K to 920.5 K (+3.81 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.95 | 52,147 | 153,834 | 886,788 | 834.6 K to 886.8 K (+6.25 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 142,500 | 356,250 | 834,641 | 692.1 K to 834.6 K (+20.59 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 112,500 | 281,250 | 692,141 | 579.6 K to 692.1 K (+19.41 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 158,334 | 395,835 | 579,641 | 421.3 K to 579.6 K (+37.58 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 1.40 | 20,834 | 29,168 | 421,307 | 400.5 K to 421.3 K (+5.20 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 1.40 | 80,730 | 113,022 | 44,270 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 2.50 | 712,491 | 1,781,228 | 187,509 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 1.02 | 83,985 | 85,665 | 9,765 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 2.04 | 202,500 | 413,100 | 0 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 12.14 | 139,706 | 1,695,696 | 217,934 | 357.6 K to 217.9 K (-39.06 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 11.14 | 55,200 | 615,110 | 357,640 | 412.8 K to 357.6 K (-13.37 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 10.27 | 884,800 | 9,090,170 | 412,840 | 1.3 M to 412.8 K (-68.19 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.40 | 80,730 | 113,022 | 1,297,640 | 1.2 M to 1.3 M (+6.63 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 2.50 | 712,491 | 1,781,228 | 1,216,910 | 504.4 K to 1.2 M (+141.25 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.02 | 83,985 | 85,665 | 504,419 | 420.4 K to 504.4 K (+19.98 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 2.04 | 202,500 | 413,100 | 420,434 | 217.9 K to 420.4 K (+92.92 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Option Exercise | M | 2.19 | 150,000 | 328,500 | 475,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Sell | S | 10.72 | 70,200 | 752,621 | 14,996 | 85.2 K to 15 K (-82.40 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Sell | S | 10.15 | 79,800 | 810,130 | 85,196 | 165 K to 85.2 K (-48.36 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Buy | M | 2.19 | 150,000 | 328,500 | 164,996 | 15 K to 165 K (+1,000.27 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Grant | A | 0.00 | 199,500 | 0 | 217,934 | 18.4 K to 217.9 K (+1,082.24 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Grant | A | 0.00 | 199,500 | 0 | 400,473 | 201 K to 400.5 K (+99.27 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Payment of Exercise | F | 2.99 | 497,876 | 1,488,649 | 2,271,785 | 2.8 M to 2.3 M (-17.98 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Grant | A | 0.00 | 1,265,250 | 0 | 2,769,661 | 1.5 M to 2.8 M (+84.10 %) |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | M | 0.00 | 37,500 | 0 | 150,000 | |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Payment of Exercise | F | 3.09 | 14,757 | 45,599 | 1,504,411 | 1.5 M to 1.5 M (-0.97 %) |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Buy | M | 0.00 | 37,500 | 0 | 1,519,168 | 1.5 M to 1.5 M (+2.53 %) |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 6,250 | 0 | 25,000 | |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 47,187 | 0 | 188,750 | |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 3.00 | 26,942 | 80,955 | 18,434 | 45.4 K to 18.4 K (-59.37 %) |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Payment of Exercise | F | 3.09 | 26,495 | 81,870 | 45,376 | 71.9 K to 45.4 K (-36.86 %) |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 6,250 | 0 | 71,871 | 65.6 K to 71.9 K (+9.52 %) |
| Jul 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 47,187 | 0 | 65,621 | 18.4 K to 65.6 K (+255.98 %) |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | M | 0.00 | 37,500 | 0 | 187,500 | |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Payment of Exercise | F | 3.01 | 14,757 | 44,419 | 1,481,668 | 1.5 M to 1.5 M (-0.99 %) |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Buy | M | 0.00 | 37,500 | 0 | 1,496,425 | 1.5 M to 1.5 M (+2.57 %) |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 6,250 | 0 | 31,250 | |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 47,187 | 0 | 235,937 | |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 2.89 | 19,042 | 55,052 | 18,434 | 37.5 K to 18.4 K (-50.81 %) |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 2.91 | 7,900 | 23,020 | 37,476 | 45.4 K to 37.5 K (-17.41 %) |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Payment of Exercise | F | 3.01 | 26,495 | 79,750 | 45,376 | 71.9 K to 45.4 K (-36.86 %) |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 6,250 | 0 | 71,871 | 65.6 K to 71.9 K (+9.52 %) |
| Apr 03 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 47,187 | 0 | 65,621 | 18.4 K to 65.6 K (+255.98 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | A | 3.80 | 558,000 | 2,120,400 | 558,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | A | 0.00 | 371,000 | 0 | 371,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | M | 0.00 | 119,667 | 0 | 239,333 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | M | 0.00 | 120,000 | 0 | 120,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Option Exercise | M | 0.00 | 260,000 | 0 | 0 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Payment of Exercise | F | 3.83 | 197,513 | 756,475 | 1,458,925 | 1.7 M to 1.5 M (-11.92 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Buy | M | 0.00 | 119,667 | 0 | 1,656,438 | 1.5 M to 1.7 M (+7.79 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Buy | M | 0.00 | 120,000 | 0 | 1,536,771 | 1.4 M to 1.5 M (+8.47 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Buy | M | 0.00 | 260,000 | 0 | 1,416,771 | 1.2 M to 1.4 M (+22.48 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Salyer Mark | Chief Commercial Of ... | Option Exercise | A | 3.80 | 117,000 | 444,600 | 117,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Salyer Mark | Chief Commercial Of ... | Option Exercise | A | 0.00 | 78,000 | 0 | 78,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | A | 3.80 | 117,000 | 444,600 | 117,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | A | 0.00 | 78,000 | 0 | 78,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 0.00 | 29,000 | 0 | 58,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 0.00 | 26,667 | 0 | 26,666 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 0.00 | 60,937 | 0 | 0 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Payment of Exercise | F | 3.83 | 57,428 | 219,949 | 200,973 | 258.4 K to 201 K (-22.22 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 0.00 | 29,000 | 0 | 258,401 | 229.4 K to 258.4 K (+12.64 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 0.00 | 26,667 | 0 | 229,401 | 202.7 K to 229.4 K (+13.15 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 0.00 | 60,937 | 0 | 202,734 | 141.8 K to 202.7 K (+42.97 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | A | 3.80 | 117,000 | 444,600 | 117,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | A | 0.00 | 78,000 | 0 | 78,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 36,000 | 0 | 72,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 26,667 | 0 | 26,666 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 0.00 | 60,937 | 0 | 0 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 3.73 | 44,857 | 167,388 | 18,434 | 63.3 K to 18.4 K (-70.87 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Payment of Exercise | F | 3.83 | 60,313 | 230,999 | 63,291 | 123.6 K to 63.3 K (-48.80 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 36,000 | 0 | 123,604 | 87.6 K to 123.6 K (+41.09 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 26,667 | 0 | 87,604 | 60.9 K to 87.6 K (+43.76 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 0.00 | 60,937 | 0 | 60,937 | 0 to 60.9 K |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Option Exercise | A | 3.80 | 117,000 | 444,600 | 117,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Option Exercise | A | 0.00 | 78,000 | 0 | 78,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Option Exercise | M | 0.00 | 29,000 | 0 | 58,000 | |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Payment of Exercise | F | 3.83 | 14,004 | 53,635 | 14,996 | 29 K to 15 K (-48.29 %) |
| Feb 02 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Buy | M | 0.00 | 29,000 | 0 | 29,000 | 0 to 29 K |